ResearcherNihon UniversityActive in the last 2 years
Tomoya Kuramochi
Matched on ORCID iD 0009-0001-0185-7941; OpenAlex author ID A5044723837. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper · 2026: 2 papers
Papers 6
- High-Dose Tramadol Enhances the Proliferative and Invasive Potential of Pancreatic Ductal Adenocarcinoma in Mice Through Microenvironmental Alteration. Co-author DOI 10.1155/prm/6594413↗
- Pregabalin enhances the proliferative potential of pancreatic cancer in vitro but not in mice with pancreatic cancer. Co-author DOI 10.1186/s40360-026-01176-2↗
- Duloxetine improves hyperosmia in mice with pancreatic cancer by increasing dopamine levels in the olfactory bulb. Co-author DOI 10.1016/j.biopha.2025.118098↗
- Effects of tramadol via a µ-opioid receptor on pancreatic ductal adenocarcinoma in vitro and in vivo. Co-author DOI 10.1136/rapm-2023-104511↗
- Mirogabalin improves cancer-associated pain but increases the risk of malignancy in mice with pancreatic cancer. Co-author DOI 10.1097/j.pain.0000000000002852↗
- Midazolam exhibits antitumour and anti-inflammatory effects in a mouse model of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.bja.2021.12.042↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Makoto Sano · 6 shared papers, 2022–2026 · strength 1.36
- Paper High-Dose Tramadol Enhances the Proliferative and Invasive Potential of Pancreatic Ductal Adenocarcinoma in Mice Throug… DOI 10.1155/prm/6594413↗
- Paper Pregabalin enhances the proliferative potential of pancreatic cancer in vitro but not in mice with pancreatic cancer. DOI 10.1186/s40360-026-01176-2↗
- Paper Duloxetine improves hyperosmia in mice with pancreatic cancer by increasing dopamine levels in the olfactory bulb. DOI 10.1016/j.biopha.2025.118098↗
- Tomoaki Itaya · 6 shared papers, 2022–2026 · strength 1.36
- Paper High-Dose Tramadol Enhances the Proliferative and Invasive Potential of Pancreatic Ductal Adenocarcinoma in Mice Throug… DOI 10.1155/prm/6594413↗
- Paper Pregabalin enhances the proliferative potential of pancreatic cancer in vitro but not in mice with pancreatic cancer. DOI 10.1186/s40360-026-01176-2↗
- Paper Duloxetine improves hyperosmia in mice with pancreatic cancer by increasing dopamine levels in the olfactory bulb. DOI 10.1016/j.biopha.2025.118098↗
- Yukino Oshima · 6 shared papers, 2022–2026 · strength 1.36
- Paper High-Dose Tramadol Enhances the Proliferative and Invasive Potential of Pancreatic Ductal Adenocarcinoma in Mice Throug… DOI 10.1155/prm/6594413↗
- Paper Pregabalin enhances the proliferative potential of pancreatic cancer in vitro but not in mice with pancreatic cancer. DOI 10.1186/s40360-026-01176-2↗
- Paper Duloxetine improves hyperosmia in mice with pancreatic cancer by increasing dopamine levels in the olfactory bulb. DOI 10.1016/j.biopha.2025.118098↗
- Hideaki Ijichi · 6 shared papers, 2022–2026 · strength 1.36
- Paper High-Dose Tramadol Enhances the Proliferative and Invasive Potential of Pancreatic Ductal Adenocarcinoma in Mice Throug… DOI 10.1155/prm/6594413↗
- Paper Pregabalin enhances the proliferative potential of pancreatic cancer in vitro but not in mice with pancreatic cancer. DOI 10.1186/s40360-026-01176-2↗
- Paper Duloxetine improves hyperosmia in mice with pancreatic cancer by increasing dopamine levels in the olfactory bulb. DOI 10.1016/j.biopha.2025.118098↗
- Ichie Kajiwara · 4 shared papers, 2022–2026 · strength 0.80
- Paper Pregabalin enhances the proliferative potential of pancreatic cancer in vitro but not in mice with pancreatic cancer. DOI 10.1186/s40360-026-01176-2↗
- Paper Effects of tramadol via a µ-opioid receptor on pancreatic ductal adenocarcinoma in vitro and in vivo. DOI 10.1136/rapm-2023-104511↗
- Paper Mirogabalin improves cancer-associated pain but increases the risk of malignancy in mice with pancreatic cancer. DOI 10.1097/j.pain.0000000000002852↗
- Takahiro Suzuki · 4 shared papers, 2022–2025 · strength 0.75
- Paper Duloxetine improves hyperosmia in mice with pancreatic cancer by increasing dopamine levels in the olfactory bulb. DOI 10.1016/j.biopha.2025.118098↗
- Paper Effects of tramadol via a µ-opioid receptor on pancreatic ductal adenocarcinoma in vitro and in vivo. DOI 10.1136/rapm-2023-104511↗
- Paper Mirogabalin improves cancer-associated pain but increases the risk of malignancy in mice with pancreatic cancer. DOI 10.1097/j.pain.0000000000002852↗
- Takahiro Suzuki · 2 shared papers, 2026 · strength 0.62
- Paper High-Dose Tramadol Enhances the Proliferative and Invasive Potential of Pancreatic Ductal Adenocarcinoma in Mice Throug… DOI 10.1155/prm/6594413↗
- Paper Pregabalin enhances the proliferative potential of pancreatic cancer in vitro but not in mice with pancreatic cancer. DOI 10.1186/s40360-026-01176-2↗
- Yoshimi Ichimaru · 3 shared papers, 2022–2024 · strength 0.50
- Paper Effects of tramadol via a µ-opioid receptor on pancreatic ductal adenocarcinoma in vitro and in vivo. DOI 10.1136/rapm-2023-104511↗
- Paper Mirogabalin improves cancer-associated pain but increases the risk of malignancy in mice with pancreatic cancer. DOI 10.1097/j.pain.0000000000002852↗
- Paper Midazolam exhibits antitumour and anti-inflammatory effects in a mouse model of pancreatic ductal adenocarcinoma. DOI 10.1016/j.bja.2021.12.042↗
- Atsushi Masamune · 3 shared papers, 2022–2024 · strength 0.50
- Paper Effects of tramadol via a µ-opioid receptor on pancreatic ductal adenocarcinoma in vitro and in vivo. DOI 10.1136/rapm-2023-104511↗
- Paper Mirogabalin improves cancer-associated pain but increases the risk of malignancy in mice with pancreatic cancer. DOI 10.1097/j.pain.0000000000002852↗
- Paper Midazolam exhibits antitumour and anti-inflammatory effects in a mouse model of pancreatic ductal adenocarcinoma. DOI 10.1016/j.bja.2021.12.042↗
- Yohei Masugi · 1 shared paper, 2022 · strength 0.13
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.